心脏骤停后高度恶性脑电图模式的预测价值:对ERC-ESICM推荐的评估
本研究为目标温度管理试验2的预设预后亚组研究,纳入845例心脏骤停患者,在骤停后中位71小时记录脑电图,评估高度恶性脑电图模式(抑制或爆发-抑制)及背景无反应性对6个月不良预后(改良Rankin量表4-6分)的预测价值。高度恶性脑电图模式预测不良预后的敏感度为50%(95%CI 46-54),特异度为93%(90-96);在541例未撤除生命维持治疗的患者中特异度相似(93%);当高度恶性脑电图模式无反应时,特异度提高至97%(94-99)(p=0.008)。作者认为,ERC-ESICM推荐的脑电图模式特异度超过90%,但低于既往研究,大规模实施可能降低其准确性;联合无反应性背景可显著提高特异度;与其他预后研究一样,自我实现的预言偏倚可能影响结果。
要点
- 心脏骤停后>24小时高度恶性脑电图模式预测6个月不良预后(mRS 4-6)的敏感度为50%(95%CI 46-54),特异度为93%(90-96)。
- 在541例未撤除生命维持治疗的患者中,高度恶性脑电图模式的特异度仍为93%,提示结果受自我实现的预言偏倚影响可能较小。
- 高度恶性脑电图模式无反应时,特异度从93%提高至97%(94-99)(p=0.008),敏感度未报告。
- ERC-ESICM指南推荐高度恶性脑电图模式需联合至少一项其他一致性预测因子,且需在心脏骤停后>24小时评估。
适用人群与场景
- 心脏骤停后成功复苏的成人患者,纳入目标温度管理试验2的预设预后亚组。
- 脑电图记录时间在心脏骤停后>24小时,中位时间为71小时(四分位距52-93小时)。
诊断标准与关键阈值
- 高度恶性脑电图模式定义为抑制或爆发-抑制。
- 不良预后定义为6个月时改良Rankin量表评分4-6分。
- 预后评估为多模式,且在心脏骤停后96小时内不允许撤除生命维持治疗。
研究设计与关键结果
- 本研究为多中心前瞻性预后亚组研究,纳入845例患者,来自59个中心。
- 579例(69%)患者出现不良预后,其中304例(36%)因神经预后不良而撤除生命维持治疗。
- 高度恶性脑电图模式预测不良预后的敏感度为50%(95%CI 46-54),特异度为93%(90-96)。
- 在541例未撤除生命维持治疗的患者中,特异度为93%。
- 当高度恶性脑电图模式无反应时,特异度提高至97%(94-99)(p=0.008)。
证据类型、等级与局限
- 证据类型:前瞻性多中心队列研究(目标温度管理试验2的预设预后亚组研究)。
- 局限:自我实现的预言偏倚可能影响观察结果。
对床旁实践的改变
- ERC-ESICM推荐在心脏骤停后>24小时使用高度恶性脑电图模式联合至少一项其他一致性预测因子来预测不良神经预后。
- 作者认为,将高度恶性脑电图模式与无反应性背景联合可显著提高特异度。
指南或共识出处
- 2021年欧洲复苏委员会(ERC)和欧洲重症监护医学会(ESICM)指南。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The 2021 guidelines endorsed by the European Resuscitation Council (ERC) and the European Society of Intensive Care Medicine (ESICM) recommend using highly malignant electroencephalogram (EEG) patterns (HMEP; suppression or burst-suppression) at > 24 h after cardiac arrest (CA) in combination with at least one other concordant predictor to prognosticate poor neurological outcome. We evaluated the prognostic accuracy of HMEP in a large multicentre cohort and investigated the added value of absent EEG reactivity.
METHODS: This is a pre-planned prognostic substudy of the Targeted Temperature Management trial 2. The presence of HMEP and background reactivity to external stimuli on EEG recorded > 24 h after CA was prospectively reported. Poor outcome was measured at 6 months and defined as a modified Rankin Scale score of 4-6. Prognostication was multimodal, and withdrawal of life-sustaining therapy (WLST) was not allowed before 96 h after CA.
RESULTS: 845 patients at 59 sites were included. Of these, 579 (69%) had poor outcome, including 304 (36%) with WLST due to poor neurological prognosis. EEG was recorded at a median of 71 h (interquartile range [IQR] 52-93) after CA. HMEP at > 24 h from CA had 50% [95% confidence interval [CI] 46-54] sensitivity and 93% [90-96] specificity to predict poor outcome. Specificity was similar (93%) in 541 patients without WLST. When HMEP were unreactive, specificity improved to 97% [94-99] (p = 0.008).
CONCLUSION: The specificity of the ERC-ESICM-recommended EEG patterns for predicting poor outcome after CA exceeds 90% but is lower than in previous studies, suggesting that large-scale implementation may reduce their accuracy. Combining HMEP with an unreactive EEG background significantly improved specificity. As in other prognostication studies, a self-fulfilling prophecy bias may have contributed to observed results.
参考来源
- Turella S, Dankiewicz J, Friberg H, et al. The predictive value of highly malignant EEG patterns after cardiac arrest: evaluation of the ERC-ESICM recommendations. Intensive Care Med. 2024. PMID: 38172300. doi:10.1007/s00134-023-07280-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。